$AMRN Company News Expedia falls on Google penal
Post# of 102379
Posted On: 01/27/2014 11:03:50 AM
$AMRN Company News
Expedia falls on Google penalty; Alcoa jumps on upgrade 3:54 p.m. Jan. 21, 2014 - Sue Chang
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 4:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Intercept, Celgene on move amid J.P. Morgan event 9:20 a.m. Jan. 13, 2014 - Victor Reklaitis
6 gut checks before the stock market's opening bell 6:12 a.m. July 8, 2013 - Shawn Langlois
6 gut checks before the stock market's opening bell 6:55 a.m. March 27, 2013 - Shawn Langlois
7 gut checks before the stock market's opening bell 7:05 a.m. Feb. 27, 2013 - Shawn Langlois
Friday’s big movers: Groupon soars on Google talk 4:38 p.m. Dec. 7, 2012 - Sue Chang
Amarin down 17% on risks tied to drug launch 8:00 a.m. Dec. 7, 2012 - Steve Gelsi
Amarin down 18% in premarket trades 7:41 a.m. Dec. 7, 2012 - Steve Gelsi
Wednesday’s biggest gaining and declining stocks 3:40 p.m. Oct. 10, 2012 - Sue Chang
Tuesday’s top gaining and declining stocks 3:57 p.m. Sept. 11, 2012 - MarketWatch
Amarin issues patent update on fish-oil drug 11:29 a.m. Sept. 5, 2012 - Val Brickates Kennedy
Amarin jumps 16% after business update 11:06 a.m. Aug. 9, 2012 - Val Brickates Kennedy
Amarin rallies 15% on business update 9:48 a.m. Aug. 9, 2012 - Val Brickates Kennedy
Amarin falls 11% on insider stock-sale reports 11:12 a.m. July 31, 2012 - Val Brickates Kennedy
Amarin, AuthenTec active; advancers outpace decliners 4-1 on NYSE 11:45 a.m. July 27, 2012 - blogs.marketwatch.com
Amarin down 9% in wake of drug approval 9:08 a.m. July 27, 2012 - Val Brickates Kennedy
Amarin gets FDA approval for Vascepa 5:09 p.m. July 26, 2012 - Wallace Witkowski
Amarin: FDA OKs Vascepa for high triglycerides 4:46 p.m. July 26, 2012 - Wallace Witkowski
Amarin halted ahead of FDA decision deadline 2:13 p.m. July 26, 2012 - Val Brickates Kennedy
Amarin Tumbles after DMEP Decision - Analyst Blog 5:10 p.m. Jan. 22, 2014 - Zacks.com
Biotech Stock Roundup: Sarepta Spikes on Data & Alnylam on Deal - Analyst Blog 1:01 p.m. Jan. 22, 2014 - Zacks.com
Get set for capital raise at Amarin after ANCHOR SPA rejection 11:23 a.m. Jan. 21, 2014 - Seeking Alpha
FDA To Amarin: 'I Said Good Day, Sir!' 10:10 a.m. Jan. 21, 2014 - Seeking Alpha
FDA division won't reinstate SPA for Amarin's Vascepa 7:47 a.m. Jan. 21, 2014 - Seeking Alpha
Amarin Announces FDA DMEP Does Not Plan to Re-instate ANCHOR SPA Agreement 4:46 a.m. Jan. 21, 2014 - benzinga.com
Amarin: Is No News Good News? 4:13 p.m. Jan. 20, 2014 - Seeking Alpha
Amarin -5% after FDA delays ANCHOR SPA appeal, MKM downgrades 12:41 p.m. Jan. 16, 2014 - Seeking Alpha
February 14th Options Now Available For Amarin (AMRN) 10:57 a.m. Jan. 16, 2014 - TheStreet.com
Benzinga's Top #PreMarket Losers 7:22 a.m. Jan. 16, 2014 - benzinga.com
Amarin Delay Piques Investor Interest And Sparks Debate 4:12 a.m. Jan. 16, 2014 - Seeking Alpha
Regulator delays decision on Amarin's Vascepa 4:10 p.m. Jan. 15, 2014 - Seeking Alpha
Amarin Announces FDA Review Division Response on ANCHOR SPA Agreement Reinstatement Request Will Be Delayed 3:05 p.m. Jan. 15, 2014 - benzinga.com
Stock Watch Monday, 13 January 2014: Intercept Soars As Focus Shifts To Healthcare Market Trends 9:06 a.m. Jan. 13, 2014 - Seeking Alpha
Amarin Out, Intercept Pharma In At J.P. Morgan Healthcare Confab 11:35 a.m. Jan. 12, 2014 - TheStreet.com
While Amarin Continues To Go Rancid, Neptune Will Soar 8:34 a.m. Jan. 11, 2014 - Seeking Alpha
Stock Watch Friday, 10 January 2013: Mannkind Rallies, Sirius Should Satisfy 8:36 a.m. Jan. 10, 2014 - Seeking Alpha
The Twitterverse's Biotech Stock Picks for 2014 8:00 a.m. Jan. 7, 2014 - TheStreet.com
Small Cap BioPharmas With Near Term Catalysts 7:55 a.m. Jan. 3, 2014 - Seeking Alpha
AMRN January 10th Options Begin Trading 11:43 a.m. Jan. 2, 2014 - TheStreet.com
Amarin Announces FDA Review Division Response to ANCHOR SPA Agreement Reinstatement Request 1:00 a.m. Jan. 21, 2014 - GlobeNewswire
Amarin Announces FDA Review Division Response on ANCHOR SPA Agreement Reinstatement Request Will Be Delayed 4:05 p.m. Jan. 15, 2014 - GlobeNewswire
Equity Technical Dimensions:Seattle Genetics, Amarin, and PerkinElmer 8:00 a.m. Dec. 27, 2013 - PR Newswire
New Drug Application Updates, Appointments, Partnership Programs, and Stock Movements - Research Report on Amarin, Oramed Pharmaceuticals, Synta Pharmaceuticals, Healthways and AMN Healthcare 8:00 a.m. Dec. 25, 2013 - PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Amarin Corp. plc and Its Board of Directors and of a Lead Plaintiff Deadline of January 3, 2014 3:29 p.m. Dec. 24, 2013 - PR Newswire
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of Amarin Corporation plc of Upcoming Deadline 11:27 a.m. Dec. 20, 2013 - BusinessWire
Important Trend Analysis: Amarin Corporation plc, Corporation, Geron Corporation, 3D Systems Corporation 10:22 a.m. Dec. 20, 2013 - ACCESSWIRE
Amarin Receives FDA Notification That Action on ANCHOR sNDA Review Will be Delayed 6:00 a.m. Dec. 20, 2013 - GlobeNewswire
SHAREHOLDER ALERT: Brower Piven Announces the Filing of a Class Action Lawsuit Against Amarin Corporation plc Expanding the Class Period to Include July 9, 2009 Through October 16, 2013 and Encourages Investors Who Have Losses in Excess of $150,000 From Investment in Amarin Corporation plc to Inquire About the Lead Plaintiff Position Before the January 3, 2014 Lead Plaintiff Deadline -- AMRN 4:59 p.m. Dec. 19, 2013 - GlobeNewswire
Amarin Announces Leadership Changes 9:07 a.m. Dec. 16, 2013 - GlobeNewswire
Glancy Binkow & Goldberg Files Class Action Lawsuit Against Amarin Corporation 9:32 p.m. Dec. 13, 2013 - BusinessWire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Amarin Corp. plc and Its Board of Directors and a Lead Plaintiff Deadline of January 3, 2014 6:27 p.m. Dec. 11, 2013 - GlobeNewswire
Proposed Offering and Amendments, Patents, Results, and Announcements by Healthcare Companies - Research Report on Forest Laboratories, OncoMed, EnteroMedics, Cadence, and Amarin 8:00 a.m. Dec. 6, 2013 - PR Newswire
Biotech Briefing: Advancing Biotechs Forging Ahead With Breaking News Developments: Alliqua, OncoMed Pharmaceuticals, EnteroMedics, Unilife, Amarin 9:05 a.m. Dec. 4, 2013 - PR Newswire
Amarin Announces Notification of Patent Allowances for U.S. Applications 13/685,281, and 13/685,291 Related to Triglyceride Lowering With a Mixture of Omega-3 Free Fatty Acid (Including EPA and/or DHA) in Both the MARINE and ANCHOR Patient Populations 6:00 a.m. Dec. 2, 2013 - GlobeNewswire
Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Amarin Corporation plc 9:32 p.m. Nov. 27, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Amarin Corporation, plc and Certain Officers - AMRN 4:56 p.m. Nov. 27, 2013 - PR Newswire
Kantrowitz, Goldhamer & Graifman, P.C. Files Class Action Suit Against Amarin Corporation plc 3:44 p.m. Nov. 27, 2013 - BusinessWire
AAAResearchReports.com Pre-Market Technical Analysis: Elan Corp., Amarin Corp., Cubist Pharmaceuticals, and Seattle Genetics 8:00 a.m. Nov. 27, 2013 - PR Newswire
Bullish Stocks Commentary: Camtek Ltd, Lions Gate Entertainment, ImmunoCellular Therapeutics, Pandora Media, Amarin Corporation 8:47 a.m. Nov. 26, 2013 - PR Newswire
Expedia falls on Google penalty; Alcoa jumps on upgrade 3:54 p.m. Jan. 21, 2014 - Sue Chang
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 4:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Intercept, Celgene on move amid J.P. Morgan event 9:20 a.m. Jan. 13, 2014 - Victor Reklaitis
6 gut checks before the stock market's opening bell 6:12 a.m. July 8, 2013 - Shawn Langlois
6 gut checks before the stock market's opening bell 6:55 a.m. March 27, 2013 - Shawn Langlois
7 gut checks before the stock market's opening bell 7:05 a.m. Feb. 27, 2013 - Shawn Langlois
Friday’s big movers: Groupon soars on Google talk 4:38 p.m. Dec. 7, 2012 - Sue Chang
Amarin down 17% on risks tied to drug launch 8:00 a.m. Dec. 7, 2012 - Steve Gelsi
Amarin down 18% in premarket trades 7:41 a.m. Dec. 7, 2012 - Steve Gelsi
Wednesday’s biggest gaining and declining stocks 3:40 p.m. Oct. 10, 2012 - Sue Chang
Tuesday’s top gaining and declining stocks 3:57 p.m. Sept. 11, 2012 - MarketWatch
Amarin issues patent update on fish-oil drug 11:29 a.m. Sept. 5, 2012 - Val Brickates Kennedy
Amarin jumps 16% after business update 11:06 a.m. Aug. 9, 2012 - Val Brickates Kennedy
Amarin rallies 15% on business update 9:48 a.m. Aug. 9, 2012 - Val Brickates Kennedy
Amarin falls 11% on insider stock-sale reports 11:12 a.m. July 31, 2012 - Val Brickates Kennedy
Amarin, AuthenTec active; advancers outpace decliners 4-1 on NYSE 11:45 a.m. July 27, 2012 - blogs.marketwatch.com
Amarin down 9% in wake of drug approval 9:08 a.m. July 27, 2012 - Val Brickates Kennedy
Amarin gets FDA approval for Vascepa 5:09 p.m. July 26, 2012 - Wallace Witkowski
Amarin: FDA OKs Vascepa for high triglycerides 4:46 p.m. July 26, 2012 - Wallace Witkowski
Amarin halted ahead of FDA decision deadline 2:13 p.m. July 26, 2012 - Val Brickates Kennedy
Amarin Tumbles after DMEP Decision - Analyst Blog 5:10 p.m. Jan. 22, 2014 - Zacks.com
Biotech Stock Roundup: Sarepta Spikes on Data & Alnylam on Deal - Analyst Blog 1:01 p.m. Jan. 22, 2014 - Zacks.com
Get set for capital raise at Amarin after ANCHOR SPA rejection 11:23 a.m. Jan. 21, 2014 - Seeking Alpha
FDA To Amarin: 'I Said Good Day, Sir!' 10:10 a.m. Jan. 21, 2014 - Seeking Alpha
FDA division won't reinstate SPA for Amarin's Vascepa 7:47 a.m. Jan. 21, 2014 - Seeking Alpha
Amarin Announces FDA DMEP Does Not Plan to Re-instate ANCHOR SPA Agreement 4:46 a.m. Jan. 21, 2014 - benzinga.com
Amarin: Is No News Good News? 4:13 p.m. Jan. 20, 2014 - Seeking Alpha
Amarin -5% after FDA delays ANCHOR SPA appeal, MKM downgrades 12:41 p.m. Jan. 16, 2014 - Seeking Alpha
February 14th Options Now Available For Amarin (AMRN) 10:57 a.m. Jan. 16, 2014 - TheStreet.com
Benzinga's Top #PreMarket Losers 7:22 a.m. Jan. 16, 2014 - benzinga.com
Amarin Delay Piques Investor Interest And Sparks Debate 4:12 a.m. Jan. 16, 2014 - Seeking Alpha
Regulator delays decision on Amarin's Vascepa 4:10 p.m. Jan. 15, 2014 - Seeking Alpha
Amarin Announces FDA Review Division Response on ANCHOR SPA Agreement Reinstatement Request Will Be Delayed 3:05 p.m. Jan. 15, 2014 - benzinga.com
Stock Watch Monday, 13 January 2014: Intercept Soars As Focus Shifts To Healthcare Market Trends 9:06 a.m. Jan. 13, 2014 - Seeking Alpha
Amarin Out, Intercept Pharma In At J.P. Morgan Healthcare Confab 11:35 a.m. Jan. 12, 2014 - TheStreet.com
While Amarin Continues To Go Rancid, Neptune Will Soar 8:34 a.m. Jan. 11, 2014 - Seeking Alpha
Stock Watch Friday, 10 January 2013: Mannkind Rallies, Sirius Should Satisfy 8:36 a.m. Jan. 10, 2014 - Seeking Alpha
The Twitterverse's Biotech Stock Picks for 2014 8:00 a.m. Jan. 7, 2014 - TheStreet.com
Small Cap BioPharmas With Near Term Catalysts 7:55 a.m. Jan. 3, 2014 - Seeking Alpha
AMRN January 10th Options Begin Trading 11:43 a.m. Jan. 2, 2014 - TheStreet.com
Amarin Announces FDA Review Division Response to ANCHOR SPA Agreement Reinstatement Request 1:00 a.m. Jan. 21, 2014 - GlobeNewswire
Amarin Announces FDA Review Division Response on ANCHOR SPA Agreement Reinstatement Request Will Be Delayed 4:05 p.m. Jan. 15, 2014 - GlobeNewswire
Equity Technical Dimensions:Seattle Genetics, Amarin, and PerkinElmer 8:00 a.m. Dec. 27, 2013 - PR Newswire
New Drug Application Updates, Appointments, Partnership Programs, and Stock Movements - Research Report on Amarin, Oramed Pharmaceuticals, Synta Pharmaceuticals, Healthways and AMN Healthcare 8:00 a.m. Dec. 25, 2013 - PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Amarin Corp. plc and Its Board of Directors and of a Lead Plaintiff Deadline of January 3, 2014 3:29 p.m. Dec. 24, 2013 - PR Newswire
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of Amarin Corporation plc of Upcoming Deadline 11:27 a.m. Dec. 20, 2013 - BusinessWire
Important Trend Analysis: Amarin Corporation plc, Corporation, Geron Corporation, 3D Systems Corporation 10:22 a.m. Dec. 20, 2013 - ACCESSWIRE
Amarin Receives FDA Notification That Action on ANCHOR sNDA Review Will be Delayed 6:00 a.m. Dec. 20, 2013 - GlobeNewswire
SHAREHOLDER ALERT: Brower Piven Announces the Filing of a Class Action Lawsuit Against Amarin Corporation plc Expanding the Class Period to Include July 9, 2009 Through October 16, 2013 and Encourages Investors Who Have Losses in Excess of $150,000 From Investment in Amarin Corporation plc to Inquire About the Lead Plaintiff Position Before the January 3, 2014 Lead Plaintiff Deadline -- AMRN 4:59 p.m. Dec. 19, 2013 - GlobeNewswire
Amarin Announces Leadership Changes 9:07 a.m. Dec. 16, 2013 - GlobeNewswire
Glancy Binkow & Goldberg Files Class Action Lawsuit Against Amarin Corporation 9:32 p.m. Dec. 13, 2013 - BusinessWire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Amarin Corp. plc and Its Board of Directors and a Lead Plaintiff Deadline of January 3, 2014 6:27 p.m. Dec. 11, 2013 - GlobeNewswire
Proposed Offering and Amendments, Patents, Results, and Announcements by Healthcare Companies - Research Report on Forest Laboratories, OncoMed, EnteroMedics, Cadence, and Amarin 8:00 a.m. Dec. 6, 2013 - PR Newswire
Biotech Briefing: Advancing Biotechs Forging Ahead With Breaking News Developments: Alliqua, OncoMed Pharmaceuticals, EnteroMedics, Unilife, Amarin 9:05 a.m. Dec. 4, 2013 - PR Newswire
Amarin Announces Notification of Patent Allowances for U.S. Applications 13/685,281, and 13/685,291 Related to Triglyceride Lowering With a Mixture of Omega-3 Free Fatty Acid (Including EPA and/or DHA) in Both the MARINE and ANCHOR Patient Populations 6:00 a.m. Dec. 2, 2013 - GlobeNewswire
Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Amarin Corporation plc 9:32 p.m. Nov. 27, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Amarin Corporation, plc and Certain Officers - AMRN 4:56 p.m. Nov. 27, 2013 - PR Newswire
Kantrowitz, Goldhamer & Graifman, P.C. Files Class Action Suit Against Amarin Corporation plc 3:44 p.m. Nov. 27, 2013 - BusinessWire
AAAResearchReports.com Pre-Market Technical Analysis: Elan Corp., Amarin Corp., Cubist Pharmaceuticals, and Seattle Genetics 8:00 a.m. Nov. 27, 2013 - PR Newswire
Bullish Stocks Commentary: Camtek Ltd, Lions Gate Entertainment, ImmunoCellular Therapeutics, Pandora Media, Amarin Corporation 8:47 a.m. Nov. 26, 2013 - PR Newswire
(0)
(0)Scroll down for more posts ▼